Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Senju

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2010
[Establishment of pluripotent stem cell-derived dendritic cells for clinical application]Satoru Senju
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
iPS-cell derived dendritic cells and macrophages for cancer therapySatoru Senju
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2008
[Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma]Yasuharu Nishimura, Tetsuya Nakatsura, Satoru Senju
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[HLA mismatch and graft rejection]Hidetake Matsuyoshi, Satoru Senju, Mikio Monji, et al.
Heliyon|November 16, 2020
Dengue virus susceptibility in novel immortalized myeloid cellsAtsushi Yamanaka, Kazuo Miyazaki, Jun Shimizu, et al.
Cancer Immunology Research|April 30, 2014
Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progressionHirotake Tsukamoto, Ryutaro Nishikata, Satoru Senju, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 2, 2011
[Cancer immunotherapy by utilizing dedritic cells derived from pluripotent stem cells]Satoshi Fukushima, Hironobu Ihn, Yasuharu Nishimura, et al.
European Journal of Immunology|March 1, 2002
Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX methodTetsuya Nakatsura, Satoru Senju, Masaaki Ito, et al.
Nature Communications|April 8, 2015
IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old ageHirotake Tsukamoto, Satoru Senju, Keiko Matsumura, et al.
Immunology Letters|August 18, 2009
An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) miceMitsuhiro Inoue, Satoru Senju, Shinya Hirata, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2010
[Establishment of pluripotent stem cell-derived dendritic cells for clinical application]Satoru Senju
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
iPS-cell derived dendritic cells and macrophages for cancer therapySatoru Senju
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2008
[Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma]Yasuharu Nishimura, Tetsuya Nakatsura, Satoru Senju
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[HLA mismatch and graft rejection]Hidetake Matsuyoshi, Satoru Senju, Mikio Monji, et al.
Heliyon|November 16, 2020
Dengue virus susceptibility in novel immortalized myeloid cellsAtsushi Yamanaka, Kazuo Miyazaki, Jun Shimizu, et al.
Cancer Immunology Research|April 30, 2014
Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progressionHirotake Tsukamoto, Ryutaro Nishikata, Satoru Senju, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 2, 2011
[Cancer immunotherapy by utilizing dedritic cells derived from pluripotent stem cells]Satoshi Fukushima, Hironobu Ihn, Yasuharu Nishimura, et al.
European Journal of Immunology|March 1, 2002
Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX methodTetsuya Nakatsura, Satoru Senju, Masaaki Ito, et al.
Nature Communications|April 8, 2015
IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old ageHirotake Tsukamoto, Satoru Senju, Keiko Matsumura, et al.
Immunology Letters|August 18, 2009
An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) miceMitsuhiro Inoue, Satoru Senju, Shinya Hirata, et al.
Pageof 10